Evaluation of the efficacy of Trachyspermum ammi topical cream on neuropathy symptoms in cancer patients

Phase 3

Conditions: eoplastic (malignant) related neuropathy.
Drug-induced polyneuropathy
G62.0

Registration Number: IRCT20131218015860N6

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: All

Target Recruitment: 40

Inclusion Criteria

Patients with cancer
Patients whose neuropathy is due to chemotherapy with taxane drugs or a history of chemotherapy taxane that is a maximum of two months from completion of chemotherapy last
Having symptoms of peripheral neuropathy
Neuropathy is based on the diagnosis of a neurologist due to chemotherapy
Aged between 18 and 80 years
Willingness to collaborate in the study

Exclusion Criteria

diabetes
Carpal tunnel syndrome
Reluctance to stay in study
Acute psychological symptoms such as depression (taking medication for it)
Unforeseen treatments such as surgery, radiation therapy or immunotherapy that were not previously part of the participant's treatment plan
Vitamin B6 deficiency or high (diagnosed by doctor and interview)
Any signs of allergy or side effects from the drug
Deterioration of the patient
renal failure
Brain metastasis
Previous history of axilla or lumbar or pelvic radiotherapy
A history of neuropathy due to other conditions that the person had before starting chemotherapy or getting cancer

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: Weeks zero and four. Method of measurement: Visual Analogue Scale.;Tingling. Timepoint: Weeks zero and four. Method of measurement: Visual Analogue Scale.;Symptoms of peripheral neuropathy. Timepoint: Weeks zero and four. Method of measurement: Chemotherapy Induced Peripheral Neuropathy Assessment Tool (CIPNAT) questionnaire.

Secondary Outcome Measures